Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
9,120.00
-160.00 (-1.72%)
At close: Feb 27, 2026
-2.88% (1Y)
| Market Cap | 212.11B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 23.26M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 276,257 |
| Average Volume | 349,353 |
| Open | 9,300.00 |
| Previous Close | 9,280.00 |
| Day's Range | 9,090.00 - 9,350.00 |
| 52-Week Range | 6,970.00 - 12,670.00 |
| Beta | 0.97 |
| RSI | 42.14 |
| Earnings Date | Nov 11, 2025 |